We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We may also share information about your use of our site with our social media, advertising and analytics partners. Read more about our Privacy Policy.

I got it!

Dr María José Oliva Martin

Senior Scientist Preclinical Cell Biology

TM London Day One

Wednesday, 6th December 2017

11.40 | Incorporating CRISPR into the pre-clinical testing of TCR-based biologic drug candidates

Dr. María José Oliva Martin is a Senior Scientist in the Preclinical Cell Biology Group at Immunocore Ltd. After graduating in Pharmacy at the University of Seville, she completed an MPhil in Translational Medicine and Therapeutics at the University of Cambridge. She conducted her PhD between the University of Seville, the University of Cambridge and the Karolinska Institute, with a focus on the role of caspases in monocyte activation and its potential in the treatment of inflammatory response syndromes. She first came across CRISPR during her postdoctoral work at the University of Oxford, where she knocked out a differentiation related protein in stem cells. At Immunocore, she has continued in the field of immunotherapy, where she is currently working across different programmes applying CRISPR to specificity testing.